# US 2026/0091111 A1 · Room temperature stable lyophilized protein

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0091111 A1
- Document ID: US20260091111A1
- Status: Published application
- Kind: A1
- Application number: 19/413,451
- Filed: 2025-12-09
- Published: 2026-04-02
- Earliest claimed: 2016-10-07
- Assignees: Regeneron Pharmaceuticals, Inc.
- Applicants: Regeneron Pharmaceuticals, Inc.
- Inventors: Xiaolin Tang; David Brett Ludwig
- Web page: https://patentgrep.com/patent/US20260091111A1

## CPC

- A61K 39/39591: {Stabilisation, fragmentation}
- A61J 1/1412: {Containers with closing means, e.g. caps}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 9/19: lyophilised {, i.e. freeze-dried, solutions or dispersions (lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00)}
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/183: {Amino acids, e.g. glycine, EDTA or aspartame}
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Stable lyophilized therapeutic protein compositions and their methods of manufacture are provided. Specifically, the use of water as a solid cake plasticizer and protein stabilizer is described. Also, the inclusion of a multicomponent stabilizer comprising a larger molecular entity and a smaller molecular entity is described. Also, the inclusion of post-drying annealing under certain conditions improves protein stability. Proteins are predicted to remain stable over 24 months at 25° C.

## Claims

### Claim 1

A lyophilized cake comprising a protein and a stabilizer, and having a moisture content greater than 2% and less than 10% by weight, wherein the stabilizer comprises trehalose.

### Claim 2 (depends on 1)

The lyophilized cake of claim 1, wherein the protein represents from about 6.27% to about 63.7% of the weight of the lyophilized cake.

### Claim 3 (depends on 1)

The lyophilized cake of claim 1, having a stabilizer to protein ratio of greater than or equal to 0.87:1.

### Claim 4 (depends on 1)

The lyophilized cake of claim 1, wherein the moisture content is from 3.5% to 8.5% by weight.

### Claim 5 (depends on 1)

The lyophilized cake of claim 1, wherein the stabilizer is present at about 19.9% to about 82.2% by weight.

### Claim 6 (depends on 1)

The lyophilized cake of claim 1, wherein less than 1.0% of the protein is aggregated after storage of 2 months at 25° C.

### Claim 7 (depends on 1)

The lyophilized cake of claim 1, wherein the trehalose is the only stabilizer included in the lyophilized cake.

### Claim 8 (depends on 7)

The lyophilized cake of claim 7, further comprising a buffer selected from the group consisting of citrate, phosphate, histidine, succinate, carbonate, acetate, and a combination thereof.

### Claim 9 (depends on 1)

The lyophilized cake of claim 1, wherein the stabilizer consists of the trehalose and an additional stabilizer selected from the group consisting of arginine, sorbitol, mannitol, glycerol, and alanine.

### Claim 10 (depends on 1)

The lyophilized cake of claim 1, further comprising a buffer.

### Claim 11 (depends on 1)

The lyophilized cake of claim 1, further comprising a surfactant.

### Claim 12 (depends on 1)

The lyophilized cake of claim 1, further comprising a polysorbate surfactant.

### Claim 13 (depends on 1)

The lyophilized cake of claim 1, wherein the lyophilized cake is not discolored red or not discolored black.

### Claim 14

A lyophilized cake comprising a protein and stabilizers, and having a moisture content from about 2.0% to about 10% by weight;
wherein the stabilizers comprise sucrose and an additional stabilizer selected among a polyol, a sugar, an amino acid, a salt and combinations thereof.

### Claim 15 (depends on 14)

The lyophilized cake of claim 14, wherein a total amount of the stabilizers makes up from about 19.9% to about 82.2% of the weight of the lyophilized cake.

### Claim 16 (depends on 14)

The lyophilized cake of claim 14, wherein the additional stabilizer is selected from the group consisting of: sorbitol, glycine, mannitol, alanine, proline, sodium chloride, glycerol, arginine, and trehalose.

### Claim 17 (depends on 14)

The lyophilized cake of claim 14, wherein less than 1.0% of the protein is aggregated after storage of 2 months at 25° C.

### Claim 18 (depends on 14)

The lyophilized cake of claim 14, having a stabilizer to protein ratio of greater than or equal to 0.87:1.

### Claim 19

A method of making a lyophilized cake, the method comprising:
freezing a pre-lyophilized aqueous solution comprising a protein, a stabilizer, and water to form a frozen composition;
primary drying the frozen composition to remove water;
after the primary drying, secondary drying the frozen composition to attain a lyophilized cake comprising a moisture content between 2% and 10% by weight; and
annealing the lyophilized cake at an annealing temperature below a glass transition temperature of the lyophilized cake.

### Claim 20 (depends on 19)

The method of claim 19, wherein the annealing temperature is above 50° C. and the annealing temperature is held for about 12 hours to about two weeks.
